In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 3, 2011, Pages 333-340

  Shegokar, Ranjita ^a,b   Jansch, Mirko ^a   Singh, Kamalinder K ^b   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b SNDT WOMEN S UNIVERSITY   (India)

Author keywords

2 D PAGE; Biodistribution; Drug targeting; HIV AIDS; NS

Indexed keywords

2-D PAGE; BIODISTRIBUTIONS; DRUG TARGETING; HIV/AIDS; NS;

ANIMALS; CHEMOTHERAPY; DISEASES; ELECTROPHORESIS; GLYCOLS; PARTICLE SIZE ANALYSIS; POLYDISPERSITY; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; PROTEINS; RESERVOIRS (WATER); TWO DIMENSIONAL;

ADSORPTION;

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN D; APOLIPOPROTEIN E; IMMUNOGLOBULIN; MACROGOL 10000; NANOCRYSTAL; NEVIRAPINE; POLYSACCHARIDE; SERUM ALBUMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADSORPTION KINETICS; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; ORGAN DISTRIBUTION; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; SUSPENSION; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADSORPTION; ANIMALS; BLOOD PROTEINS; CHEMISTRY, PHARMACEUTICAL; HUMANS; NANOPARTICLES; NEVIRAPINE; POLYETHYLENE GLYCOLS; POLYSACCHARIDES; RADIOACTIVITY; RATS; SUSPENSIONS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 79956344194     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2010.10.012     Document Type: Article

References (42)

1. Müller R.H., Souto E.B., Göppert T.M., Gohla S. Production of biofunctionalized solid lipid nanoparticles (SLN®) for site-specific drug delivery. Nanotechnologies for the Life Sciences Vol. 2: Biological and Pharmaceutical Nanomaterials 2006, Kumar CSSR, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
2. Moghimi S.M., Muir I.S., Illum L., Davis S.S., Kolb-Bachofen V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1993, 1179:157-165.
3. Göppert T.M., Müller R.H. Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. J Drug Target 2003, 11:225-231.
4. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Del Rev 2001, 47:65-81.
5. Kreuter J., Petrov V.E., Kharkevich D.A., Alyautdin R.N. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles. J Control Rel 1997, 49:81-87.
6. Kreuter J., Shamenkov D., Petrov V., Ramge P., Cychutek K., Koch-Brandt C., et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 2002, 10:317-325.
7. Shehata T., Ogawara K., Higaki K., Kimura T. Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int J Pharm 2008, 359:272-279.
8. Gessner A., Paulke B.R., Müller R.H. Analysis of plasma protein adsorption onto polystyrene particles by two-dimensional electrophoresis: comparison of sample application and isoelectric focusing techniques. Electrophoresis 2000, 21:2438-2442.
9. Leroux J.C., De Jaeghere F., Anner B., Doelker E., Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci 1995, 57:695-703.
10. Peracchia M.T., Fattal E., Desmaele D., Besnard M., Noel J.P., Gomis J.M., et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Rel 1999, 60:121-128.
11. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000, 18:301-313.
12. Zhang Y., Kohler N., Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23:1553-1561.
13. Gupta A.K., Curtis A.S. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 2004, 15:493-496.
14. Gessner A., Paulke B.R., Müller R.H., Göppert T.M. Protein rejecting properties of PEG-grafted nanoparticles: influence of PEG-chain length and surface density evaluated by two - dimensional electrophoresis and bicinchoninic acid (BCA)- protein assay. Pharmazie 2006, 61:293-297.
15. Owens D.E., Peppas N.A. Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307:93-102.
16. Jorgensen L., Wood G.K., Rosenkrands I., Petersen C., Christensen D. Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF). J Liposome Res 2009, 19:99-104.
17. Illum L., Davis S.S., Müller R.H., Mak E., West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer- poloxamine 908. Life Sci 1987, 40:367-374.
18. Babensee J.E., Cornelius R.M., Brash J.L., Sefton M.V. Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: human serum proteins in vitro and rat proteins following implantation. Biomaterials 1998, 19:839-849.
19. Yamazaki A., Winnik F.M., Cornelius R.M., Brash J.L. Modification of liposomes with N-substituted polyacrylamides: identification of proteins adsorbed from plasma. Biochim Biophys Acta 1999, 1421:103-115.
20. Juliano R.L. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv Drug Deliv Rev 1988, 2:31-54.
21. Müller R.H., Heinemann S. Surface Modelling of Microparticles as Parenteral Systems with High Tissue Affinity. Bioadhesion - Possibilities and Future Trends 1989, 202-214. Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany. R. Gurny, H.E. Junginger (Eds.).
22. Price M.E., Cornelius R.M., Brash J.L. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma. Biochim Biophys Acta 2001, 1512:191-205.
23. Camner P., Lundborg M., Lastbom L., Gerde P., Gross N., Jarstrand C. Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. J Appl Physiol 2002, 92:2608-2616.
24. Ogawara K., Furumoto K., Nagayama S., Minato K., Higaki K., Kai T., et al. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J Control Rel 2004, 100:451-455.
25. Kim H.R., Andrieux K., Gil S., Taverna M., Chacun H., Desmaele D., et al. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Biomacromolecules 2007, 8:793-799.
26. Kang S.C., Jo Y.J., Bak J.P., Kim K.C., Kim Y.S. Evaluation for protein binding affinity of maghemite and magnetite nanoparticles. J Nanosci Nanotechnol 2007, 7:3706-3708.
27. Blunk T., Hochstrasser D.F., Sanchez J.C., Müller B.W., Müller R.H. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1993, 14:1382-1387.
28. Seehof K., Kresse M., Mader K., Müller R.H. Interactions of nanoparticles with body proteins- improvement of 2D-PAGE-analysis by internal standard. Int J Pharm 2000, 196:231-234.
29. Thode K., Luck M., Semmler W., Müller R.H., Kresse M. Determination of plasma protein adsorption on magnetic iron oxides. Sample preparation. Pharm Res 1997, 14:905-910.
30. Sawant R.M., Hurley J.P., Salmaso S., Kale A., Tolcheva E., Levchenko T.S., et al. ″ SMART″ drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 2006, 17:943-949.
31. Feng L., Andrade J.D. Protein adsorption on low-temperature isotropic carbon: I. Protein conformational change probed by differential scanning calorimetry. J Biomed Mater Res 1994, 28:735-743.
32. Servoli E., Maniglio D., Aguilar M.R., Motta A., San Roman J., Belfiore L.A., et al. Quantitative analysis of protein adsorption via atomic force microscopy and surface plasmon resonance. Macromol Biosci 2008, 8:1126-1134.
33. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250:4007-4021.
34. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues: a novel approach to testing for induced point mutations in mammals. Humangenetik 1975, 26:231-243.
35. Anderson L., Anderson N.G. High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci U S A 1977, 74:5421-5425.
36. Harnisch S., Müller R.H. Plasma protein adsorption patterns on emulsions for parenteral administration: Establishment of a protocol for two - dimensional polyacrylamide electrophoresis. Electrophoresis 1998, 19:349-354.
37. Lück M., Paulke B.P., Schröder W., Müller R.H. Two - dimensional electrophoresis (2-DE) for the determination of plasma proteins adsorbed on model drug carriers. Future Strategies for Drug Delivery with Particulate Systems 1998, 109-117. CRC Press Boca Raton, Diederichs JE and Müller RH.
38. Göppert T.M., Müller R.H. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur J Pharm Biopharm 2005, 60:361-372.
39. Blunk T. Plasmaproteinadsorption auf kolloidalen Arzneistoffträgern, Dissertation, Christian-Albrechts-Universität zu Kiel 1994.
40. Mosqueira V.C., Legrand P., Morgat J.L., Vert M., Mysiakine E., Gref R., et al. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: Effects of PEG chain length and density. Pharm Res 2001, 18:1411-1419.
41. Shegokar R. Development and evaluation of novel drug delivery systems for an anti-HIV Drugs, Ph.D Dissertation, S.N.D.T. Women's University, Mumbai, India 2010.
42. Blunk T., Lück M., Calvör A., Hochstrasser D.F., Sanchez J.C., Müller B.W., et al. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting. Eur J Pharm Biopharm 1996, 42:262-268.